Where does OptiNose AS rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), OptiNose AS ranks #7,057 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does OptiNose AS hold?

OptiNose AS holds 47 US utility patents granted between 2015 and 2022, spanning 6 technology areas.

What is OptiNose AS's Innovation Score?

OptiNose AS has an Innovation Score of 34.2 out of 100 (47th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is OptiNose AS's patent grant rate increasing or decreasing?

OptiNose AS's recent grant velocity is -66% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for OptiNose AS's patents?

OptiNose AS's patents average 19.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the OptiNose AS patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

OptiNose AS

Q: What technology areas does OptiNose AS focus on?

OptiNose AS's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 41 patents, ranking #171 of 3,490 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

USPTO PatentsView assignee record - 47 granted patents across 6 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Optinose ranks #7,057 of 49,997 tracked US assignees by granted-patent volume, with 47 patents across 6 technology areas.

#7,057
of 49,997 US assignees by volume: 47th percentile
by Innovation Score (34.2/100): 19.7
avg claims per patent: -66%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7057 · Foreign Corporation #7,057 · 47 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 47 grants
UPPER-Q #7,057/49,997
PHOTO-FINISH National Institute…
CPC-NARROW A61M · 6 areas
INNOV-THIN 34.2/100
CLAIMS-RICH 19.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -66% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: National Institute of Clean-and-Low-Carbon Energy (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Optinose’s 34.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.4 pts (39%) Velocity 0.4 pts (1%) Breadth 8.7 pts (25%) Claim depth 11.8 pts (34%)

Qualcomm Incorporated · highest

85
Hill-Rom Services PTE · near

34
Transgene · near

34
OptiNose AS · this assignee

34
Virident Systems · near

34
Woobo Tech · near

34
3D Lighting… · lowest

7

What this shows Optinose's Innovation Score is 34.2/100 (47th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Optinose?

Each dot is one of Optinose’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Optinose’s own 19.7 claims/patent is ABOVE the 15.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Optinose vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Optinose's grants concentrate

OptiNose AS is a focused PatentsView assignee: 6 CPC subclasses with 87.2% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2015 (14 grants) versus a trough of 1 in 2022. By volume, Optinose sits between National Institute of Clean-and-Low-Carbon Energy and Profil Verbindungstechnik GmbH & Co. KG.

Optinose's three-year grant acceleration

OptiNose AS shows 1 grants in 2022–2024 against only 17 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

National Institut…

47
Nextiva

47
Nyxoah

47
Ospedale SAN Raff…

47
Pfeiffer Vacuum

47
Pharnext

47
Plaid

47
Profil Verbindung…

47
Optinose AS ◀

47

What this shows OptiNose holds 47 patents at rank #7,057, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near OptiNose

By rank, the assignees closest to #7,057 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in OptiNose's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for OptiNose, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), OptiNose ranks #171 of 3,490 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (34 here).

Hill-Rom Services PTE. Ltd. 34 Virident Systems, LLC 34 Woobo Tech Co., Ltd. 34 Transgene SA 34

Optinose's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 47th percentile higher than 47% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

OptiNose AS patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	14	29.8%
2016	7	14.9%
2017	2	4.3%
2018	6	12.8%
2019	6	12.8%
2020	7	14.9%
2021	4	8.5%
2022	1	2.1%

Which technologies does OptiNose AS patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 41

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 8

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 4

H01M - Processes OR Means, e.g. Batteries, FOR THE Direct Conversion OF Chemical Energy Into Electrical Energy 1

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 1

A61B - DIAGNOSIS; SURGERY; Identification 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

OptiNose AS's patent record in context - here's where to go next.

OptiNose AS's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 87.2% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #7,057 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare OptiNose AS against National Institute of Clean-and-Low-Carbon Energy, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.